Anika Therapeutics reported $28.56M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Abbott USD 7.34B 22M Sep/2026
Agios Pharmaceuticals USD 37.84M 2.09M Sep/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Halozyme Therapeutics USD 132.61M 4.52M Sep/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 163.95M 21.56M Sep/2026
Integra LifeSciences USD 464.45M 27.55M Sep/2026
Intrexon USD 287K 68K Dec/2022
J&J USD 15.38B 233M Sep/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 14.51M 4.24M Sep/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Merit Medical Systems USD 391.02M 16.91M Sep/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Sanofi EUR 24.12B 620M Jun/2026
Stryker USD 5.75B 226M Sep/2026
Veracyte USD 25.82M 3.16M Sep/2026
Zimmer Biomet Holdings USD 2.37B 96.9M Sep/2026